These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32473247)

  • 21. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
    Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
    Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model.
    Wang H; Wang H; Cheng H; Che Z
    Mol Med Rep; 2016 May; 13(5):4215-20. PubMed ID: 27035793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylserine liposomes containing curcumin inhibit bone loss in osteoporotic rats: A possible synergy through a common signaling pathway.
    Partoazar A; Goudarzi R
    J Food Biochem; 2022 Jul; 46(7):e14120. PubMed ID: 35229314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential metformin dose-dependent effects on cognition in rats: role of Akt.
    Mostafa DK; Ismail CA; Ghareeb DA
    Psychopharmacology (Berl); 2016 Jul; 233(13):2513-24. PubMed ID: 27113224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease.
    Pilipenko V; Narbute K; Pupure J; Langrate IK; Muceniece R; Kluša V
    Eur J Pharmacol; 2020 Aug; 881():173290. PubMed ID: 32580040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent effects of dimethyl fumarate on cognitive and neuropathological features in the streptozotocin-induced rat model of Alzheimer's disease.
    Majkutewicz I; Kurowska E; Podlacha M; Myślińska D; Grembecka B; Ruciński J; Pierzynowska K; Wrona D
    Brain Res; 2018 May; 1686():19-33. PubMed ID: 29453958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin improved memory impairment caused by chronic ethanol consumption during adolescent to adult period of rats: Role of oxidative stress and neuroinflammation.
    Baradaran Z; Vakilian A; Zare M; Hashemzehi M; Hosseini M; Dinpanah H; Beheshti F
    Behav Brain Res; 2021 Aug; 411():113399. PubMed ID: 34087254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
    Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ
    Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.
    Hashemi-Firouzi N; Shahidi S; Soleimani-Asl S; Komaki A
    Metab Brain Dis; 2018 Aug; 33(4):1243-1253. PubMed ID: 29667108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer's disease.
    Rompicherla SKL; Arumugam K; Bojja SL; Kumar N; Rao CM
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1737-1755. PubMed ID: 34086100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sinapic acid on memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats.
    Shahmohamady P; Eidi A; Mortazavi P; Panahi N; Minai-Tehrani D
    Pol J Pathol; 2018; 69(3):266-277. PubMed ID: 30509053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease.
    Kheradmand E; Hajizadeh Moghaddam A; Zare M
    Biomed Pharmacother; 2018 Jan; 97():1096-1101. PubMed ID: 29136946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats.
    Deshmukh R; Kaundal M; Bansal V; Samardeep
    Biomed Pharmacother; 2016 Jul; 81():56-62. PubMed ID: 27261577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model.
    Elcioğlu HK; Aslan E; Ahmad S; Alan S; Salva E; Elcioglu ÖH; Kabasakal L
    Mol Cell Biochem; 2016 Sep; 420(1-2):21-8. PubMed ID: 27443846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
    Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
    Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of memory deficits in the rat model of Alzheimer's disease by erythropoietin-loaded solid lipid nanoparticles.
    Dara T; Vatanara A; Sharifzadeh M; Khani S; Vakilinezhad MA; Vakhshiteh F; Nabi Meybodi M; Sadegh Malvajerd S; Hassani S; Mosaddegh MH
    Neurobiol Learn Mem; 2019 Dec; 166():107082. PubMed ID: 31493483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type.
    Pacheco SM; Soares MSP; Gutierres JM; Gerzson MFB; Carvalho FB; Azambuja JH; Schetinger MRC; Stefanello FM; Spanevello RM
    J Nutr Biochem; 2018 Jun; 56():193-204. PubMed ID: 29587242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.